
Qufora, formerly known as MBH-International, has exited 2021 with significant advances on its top line.
According to the Danish medtech firm’s recently publicized full-year report, Qufora booked a DKK 125.2m (USD 17.7m) revenue in the now concluded year, equating to 20% growth compared to the preceding year.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app